Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

News Daily News

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

Michael O'Riordan

December 19, 2023

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Daily News

Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s

Michael O'Riordan

November 29, 2023

News Daily News

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Todd Neale

November 22, 2023

News Conference News AHA 2023

Reductions in Plaque, Inflammation Appear to Explain Statin Benefit in HIV

Todd Neale

November 17, 2023

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Conference News AHA 2023

Automatic Scripts, Pharmacist Phone Calls Boost Statin Prescribing

Shelley Wood

November 14, 2023

Presentation AHA 2023

Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program

Presenter: Alexander C. Fanaroff

November 13, 2023

News Conference News AHA 2023

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

Shelley Wood

November 13, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

Aggressive Lipid-Lowering Very Unlikely to Hurt the Brain: AHA

Todd Neale

September 19, 2023

News Daily News

Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets

Michael O'Riordan

September 14, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Conference News ESC 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Michael O'Riordan

September 01, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Daily News

TCTMD’s Michael O’Riordan Wins Digital Health Award

Shelley Wood

August 22, 2023

News Daily News

Statin Therapy Still Lacking for Many US Patients With ASCVD

L.A. McKeown

August 07, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

Advertisement

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Reductions in Plaque, Inflammation Appear to Explain Statin Benefit in HIV

Mortality Risk Varies Among Patients With Very High LDL Levels

Automatic Scripts, Pharmacist Phone Calls Boost Statin Prescribing

Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Aggressive Lipid-Lowering Very Unlikely to Hurt the Brain: AHA

Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

TCTMD’s Michael O’Riordan Wins Digital Health Award

Statin Therapy Still Lacking for Many US Patients With ASCVD

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content